###begin article-title 0
###xml 103 108 <span type="species:ncbi:9606">human</span>
Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21)
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 291 295 291 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 740 744 740 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr/</sup>
###xml 747 750 747 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 754 757 754 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 813 816 813 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1039 1043 1039 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1126 1133 1126 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1143 1151 1143 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1286 1290 <span type="species:ncbi:10090">mice</span>
###xml 1421 1426 <span type="species:ncbi:10090">mouse</span>
###xml 1463 1467 <span type="species:ncbi:10090">mice</span>
The involvement of complement receptor 2 (CR2) in B cell tolerance and autoimmune disease has been revealed over the past decade or so. Our previous studies have established that mice prematurely expressing human CR2 under the control of a lambda light chain promoter (in particular the hCR2high line) have a marked deficit in their immune response to various antigens and fail to develop collagen-induced arthritis. This phenotype appears to be the result of irreversible changes in B cell signalling pathways and suggested that hCR2 expressing mice are protected from developing autoimmune disease. To test this hypothesis, we examined the ability of the hCR2 to block the development of spontaneous autoimmune disease on the C57BL/6j-Faslpr/Faslpr (B6lpr) background. We found that expression of hCR2 on the B6lpr background resulted in a significant reduction in levels of anti-nuclear antibodies (ANA) generated as mice aged but the levels of ANA were still higher than those found in age matched C57BL/6j (B6) mice. B cells from hCR2high mice were found to display a higher baseline level of apoptosis, whether analysed ex vivo or after in vitro culture, than their B6 counterparts and this was apparently linked to both surface IgM expression by the B cells and C3 levels in the mice. Our data also provides evidence that B cell survival in the presence of hCR2 is heavily modified by the background strain of the mouse. Overall, we have demonstrated that mice expressing hCR2 on their B cells during bone marrow development display a higher degree of apoptosis which may lead to a deletion of autoreactive B cells and be protective against the development of autoimmune disease.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 277 319 277 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27 bib46" ref-type="bibr">Marquart et al., 1995; Wilson et al., 1986</xref>
###xml 427 430 427 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 472 494 472 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr">Takahashi et al., 1997</xref>
###xml 548 551 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cr2</italic>
###xml 620 623 620 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cr2</italic>
###xml 623 626 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 628 667 628 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24 bib31" ref-type="bibr">Kurtz et al., 1990; Molina et al., 1990</xref>
###xml 796 811 796 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib48" ref-type="bibr">Wu et al., 2002</xref>
###xml 973 993 973 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">Boackle et al., 2001</xref>
###xml 1292 1349 1292 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9 bib15 bib33" ref-type="bibr">Carroll, 2000; Fischer et al., 1996; Prodeus et al., 1998</xref>
###xml 1510 1525 1510 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib47" ref-type="bibr">Wu et al., 2007</xref>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
###xml 399 405 <span type="species:ncbi:10090">murine</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 572 577 <span type="species:ncbi:10090">mouse</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1382 1387 <span type="species:ncbi:9606">human</span>
###xml 1500 1508 <span type="species:ncbi:9606">patients</span>
The suggestion that complement receptor type 2 (CR2) expression levels might be important in autoimmune disease arose from two studies that noted a marked down regulation of CR2 expression levels on B lymphocytes isolated from patients with systemic lupus erythematosus (SLE) (Marquart et al., 1995; Wilson et al., 1986). The reduction in CR2 expression levels on B cells as disease progressed in a murine model of SLE (the MRLlpr model) further supported this assertion (Takahashi et al., 1997). Indeed, data generated using mice deficient in the Cr2 gene (encoding both mouse CR1 and CR2 through alternative splicing; Cr2-/- (Kurtz et al., 1990; Molina et al., 1990)), appeared to confirm that both these proteins were important in the development of auto-antibodies in lupus susceptible mice (Wu et al., 2002). However, probably the most compelling evidence to link CR2 function to the onset of lupus arose from a study of lupus susceptibility loci in the NZM2410 mice (Boackle et al., 2001). This study identified a genetic polymorphism that results in the addition of a novel glycosylation site on the CR2 protein. This interferes with binding to its main ligand, C3d, and supported previous work suggesting a necessity for B cell signalling through CR2 in maintaining B cell tolerance (Carroll, 2000; Fischer et al., 1996; Prodeus et al., 1998). A genetic polymorphism in the human CR2 promoter region (that directly influenced CR2 expression levels) was recently identified in a cohort of SLE patients (Wu et al., 2007), again suggesting that CR2 expression level and/or functionality was highly important in overall B cell function.
###end p 6
###begin p 7
###xml 384 459 384 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14 bib31 bib32 bib45" ref-type="bibr">Fingeroth, 1990; Molina et al., 1990; Moore et al., 1987; Weis et al., 1988</xref>
###xml 656 659 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cr2</italic>
###xml 662 685 662 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">Ahearn and Fearon, 1989</xref>
###xml 863 906 863 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37 bib38" ref-type="bibr">Takahashi et al., 1997; Tedder et al., 1984</xref>
###xml 1113 1120 1113 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1196 1288 1196 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17 bib19 bib20 bib42" ref-type="bibr">Gustavsson et al., 1995; Hebell et al., 1991; Heyman et al., 1990; Thyphronitis et al., 1991</xref>
###xml 1392 1395 1392 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cr2</italic>
###xml 1395 1398 1395 1398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1405 1464 1405 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib18 bib30" ref-type="bibr">Ahearn et al., 1996; Haas et al., 2002; Molina et al., 1996</xref>
###xml 1467 1470 1467 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cr2</italic>
###xml 1470 1473 1470 1473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1550 1567 1550 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">Haas et al., 2002</xref>
###xml 1603 1643 1603 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib30" ref-type="bibr">Ahearn et al., 1996; Molina et al., 1996</xref>
###xml 1807 1819 1807 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">Holers, 2005</xref>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
###xml 734 739 <span type="species:ncbi:9606">human</span>
###xml 744 749 <span type="species:ncbi:10090">mouse</span>
###xml 1399 1403 <span type="species:ncbi:10090">mice</span>
###xml 1474 1478 <span type="species:ncbi:10090">mice</span>
###xml 1790 1795 <span type="species:ncbi:10090">mouse</span>
CR2 is expressed primarily on mature B cells and follicular dendritic cells (FDC) in both human and mouse. hCR2 and mCR2 have a high degree of homology both at the nucleotide and protein level being approximately 150 kDa in size and consisting of an extracellular domain, made of 15 or 16 tandem short consensus repeats (SCR), a transmembrane domain and a short intracellular domain (Fingeroth, 1990; Molina et al., 1990; Moore et al., 1987; Weis et al., 1988). However, one important difference between these two species is that hCR2 and hCR1 are the products of two separate genes whilst mCR1 and mCR2 are the products of one alternatively spliced gene (Cr2) (Ahearn and Fearon, 1989). In the normal situation, expression of CR2 on human and mouse B lymphocytes is restricted to transitional B cells and mature B cells as well as marginal zone and B-1 B cells (Takahashi et al., 1997; Tedder et al., 1984). B cells at earlier stages of development do not express CR2. The role for CR2 in the development and maintenance of the humoral response to T-dependent (TD) antigens (Ags) was first discovered by several in vivo studies using CR1/2 blocking Abs and a study using CR2-IgG fusion protein (Gustavsson et al., 1995; Hebell et al., 1991; Heyman et al., 1990; Thyphronitis et al., 1991). This role was confirmed and expanded by the independent generation, by gene targeting, of 3 lines of Cr2-/- mice (Ahearn et al., 1996; Haas et al., 2002; Molina et al., 1996). Cr2-/- mice have been shown to have a defect in response to T-independent (TI) Ag (Haas et al., 2002) and to T-dependent (TD) antigens (Ahearn et al., 1996; Molina et al., 1996) as well as many other facets of the humoral immune response and clearly demonstrate that CR2 is central to the breadth of B cell function in the mouse (reviewed (Holers, 2005)).
###end p 7
###begin p 8
###xml 109 200 109 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7 bib13 bib29 bib39" ref-type="bibr">Bradbury et al., 1992; Fearon and Carter, 1995; Matsumoto et al., 1991; Tedder et al., 1994</xref>
###xml 567 580 567 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr">Rickert, 2005</xref>
###xml 704 750 704 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25 bib26" ref-type="bibr">Marchbank et al., 2002; Marchbank et al., 2000</xref>
###xml 761 765 761 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 911 933 911 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26" ref-type="bibr">Marchbank et al., 2000</xref>
###xml 1017 1021 1017 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1141 1148 1141 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1202 1266 1202 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4 bib23 bib25" ref-type="bibr">Birrell et al., 2005; Kulik et al., 2007; Marchbank et al., 2002</xref>
###xml 1409 1413 1409 1413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1467 1471 1467 1471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1566 1584 1566 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Kulik et al., 2007</xref>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 1022 1026 <span type="species:ncbi:10090">mice</span>
###xml 1414 1418 <span type="species:ncbi:10090">mice</span>
###xml 1472 1476 <span type="species:ncbi:10090">mice</span>
CR2 is known to exert potent B cell signalling through non-covalent association with CD19 and CD81 (TAPA-1) (Bradbury et al., 1992; Fearon and Carter, 1995; Matsumoto et al., 1991; Tedder et al., 1994). The co-ligation of this signalling complex and the B cell receptor (BCR) are thought to form the basis of CR2s role in the humoral immune response and in the maintenance of B cell tolerance. However, the definitive roles of each of the molecules involved (antigen coated with C3d, CR2, CD19, CD81 and the BCR) remain an area of intense study and debate (reviewed (Rickert, 2005)). In order to investigate the role of CR2 in B cell function, we have previously generated several distinct hCR2 tg mice (Marchbank et al., 2002; Marchbank et al., 2000). The hCR2high mice express hCR2 during the early stages of B cell development unlike endogenous mCR1/2 or hCR2 tg mice created using a hCR2 genomic fragment, (Marchbank et al., 2000) under the control of a B cell-specific lambda promoter/enhancer minigene. The hCR2high mice display a 40-60% reduction in mature B cell numbers and the remaining mature B cells failed to respond adequately in vivo when challenged with a number of TD and TI antigens (Birrell et al., 2005; Kulik et al., 2007; Marchbank et al., 2002). We have recently found evidence of alteration in tyrosine phosphorylation patterns in response to BCR and CR2/CD19 cross-linking in the hCR2high mice and demonstrated that these changes protect hCR2high mice from the onset of an organ specific autoimmune disease collagen-induced arthritis (CIA) (Kulik et al., 2007).
###end p 8
###begin p 9
###xml 114 118 114 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 229 246 229 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">Izui et al., 1984</xref>
###xml 537 581 537 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib22" ref-type="bibr">Cohen and Eisenberg, 1991; Izui et al., 1984</xref>
###xml 595 598 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 714 819 714 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib22 bib40 bib41" ref-type="bibr">Cohen and Eisenberg, 1991; Izui et al., 1984; Theofilopoulos and Dixon, 1985; Theofilopoulos et al., 1985</xref>
###xml 871 874 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
In order to further investigate the resistance of hCR2 tg mice to onset of autoimmune disease, we crossed the hCR2high mice onto the B6lpr background. B6 mice do not readily develop autoimmune disease under normal circumstances (Izui et al., 1984). However, B6 mice deficient for Fas (CD95) develop a mild lupus-like disease characterized by lymphadenopathy, splenomegaly and production of increased titers of IgG antibodies to a variety of auto-antigens including DNA, anti-nuclear antigens (ANA), and the Fc portion of autologous IgG (Cohen and Eisenberg, 1991; Izui et al., 1984). Notably, B6lpr mice do not develop the renal failure or arthritis associated with the deficiency in Fas in other strains of mice (Cohen and Eisenberg, 1991; Izui et al., 1984; Theofilopoulos and Dixon, 1985; Theofilopoulos et al., 1985). Herein, we show that expression of hCR2 in the B6lpr mice significantly reduces the level of ANA generated and we establish that hCR2 expression on B cells in the bone marrow results in increased B cell apoptosis at the point of BCR expression, suggesting an increase in negative selection.
###end p 9
###begin title 10
Materials and methods
###end title 10
###begin title 11
Cells
###end title 11
###begin p 12
###xml 757 758 756 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
Peripheral blood lymphocytes (PBL) from mice were collected into 20 mul of heparin via a tail bleed and washed once in cold PBS. Bone marrow B cells were collected by flushing mouse femurs with cold PBS. Isolated spleens were ground into single cell suspensions using frosted glass slides and transferred to 15 ml conical tubes on ice. Large debris settled after a 10 min incubation and the supernatant was transferred to a new tube. Cells were pelleted and washed once with staining buffer (PBS, 1% FBS, 0.02% sodium azide). All samples derived from mice were incubated with 0.5-1 ml of ammonium chloride red blood cell (RBC) lysis buffer at room temperature for 1-2 min. The cells were then washed with 1 ml staining buffer 1-2 times, counted and 1-3 x 106 cells/ml used per analysis. Cells were then stained as described below.
###end p 12
###begin title 13
Antibodies
###end title 13
###begin p 14
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Purified and biotinylated (b) 171 (anti-hCR2) and b7E9 (anti-mCR1/2), purified and bIgG1 (isotype control) were produced in the laboratory from hybridomas following standard methods. Purified 2.4G2 (anti-mCD16/mCD32, Fc Block), phycoerythrin (PE) conjugated B-Ly-4 (anti-hCR2), fluorescein (FITC) or allophycocynin (APC) conjugated RA3-6B2 (anti-mCD45R, B220), biotin-conjugated 145-2C11 (anti-CD3epsilon), FITC-Annexin V, Propidium Iodide (PI) and Streptavidin (SA) - APC were all obtained from Pharmingen (BD, Cowley, Oxford). SA-PE and anti-IgM-Cy5.5 were obtained from Jackson labs (Stratech Scientific,UK). CaspACE (FITC-VAD-FMK) was obtained from (Promega, Madison, WI, USA).
###end p 14
###begin title 15
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 15
###begin p 16
###xml 42 46 42 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 206 252 206 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25 bib26" ref-type="bibr">Marchbank et al., 2002; Marchbank et al., 2000</xref>
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cr2</italic>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 312 331 312 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">Molina et al., 1996</xref>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 472 491 472 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43" ref-type="bibr">Twohig et al., 2007</xref>
###xml 584 588 584 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 613 616 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 620 623 620 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 627 630 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 731 734 731 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 794 837 794 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36 bib25" ref-type="bibr">Sekine et al., 2001; Marchbank et al., 2002</xref>
###xml 842 846 842 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr.</sup>
###xml 846 850 846 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hCR2</sup>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 21 36 <span type="species:ncbi:10090">transgenic mice</span>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
###xml 99 103 <span type="species:ncbi:10090">P1-5</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
The lambda human CR2 transgenic mice (hCR2high and hCR2int) and the genomic hCR2 transgenic mouse (P1-5) used in this study were generated and screened by PCR and/or flow cytometry as previously described (Marchbank et al., 2002; Marchbank et al., 2000). Additional mice used are F7-10 on the Cr2-/- background (Molina et al., 1996) (confirmed by PCR or flow cytometry using b7E9), F6-F8 on the C3-/- background (screened by ELISA or Western Blot as previously described (Twohig et al., 2007)), F4 on the DBA1/j (DBA) background or on a C57Bl/6j (B6) background as indicated. The hCR2high mice on the C57BL/6j-Faslpr/Faslpr (B6lpr) background were generated by back crossing for four generations whilst screening for homozygous Faslpr defect and hCR2 expression by PCR as previously described (Sekine et al., 2001; Marchbank et al., 2002) (B6lpr.hCR2).
###end p 16
###begin title 17
Flow cytometry
###end title 17
###begin p 18
After RBC lysis, cells were washed and resuspended in 10 mug/ml of 2.4G2 antibody in order to block Fc receptors. After 15 min incubation on ice, cells were washed in staining buffer. Cells were resuspended in 100 mul staining buffer containing primary Ab (0.1-3 mug/ml) and 1 mul anti-B220-FITC or APC, where appropriate. Cells were incubated for 30 min on ice in the dark. After incubation, cells were washed in staining buffer 3 times and then incubated with the appropriate streptavidin conjugated fluorochrome to detect biotin labeled primary Abs. Following incubation, cells were washed as above and then resuspended in staining buffer containing 1% formaldehyde. Flow cytometry was carried using a Becton-Dickinson FACS calibur (Oxford, UK).
###end p 18
###begin title 19
Apoptosis analysis
###end title 19
###begin p 20
###xml 487 488 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 524 525 521 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cells were collected from spleen or bone marrow as described above. B cells were identified using B220-APC and incubated with CaspACE according to manufacturers guidance (Promega, UK). On some occasions cells were also stained using B220-APC to identify B cells followed by PI and Annexin V FITC apoptosis kit (provided by BD Pharmingen, Oxford, UK). Samples were then immediately analysed by flow cytometer. Alternatively, cells were washed 3x in RPMI before being resuspended at 3 x 106 cell/ml in RPMI/10% FBS/ 0.01% beta2-mercaptoethanol in 24 well plates. Plates were cultured in standard conditions for 16 h. Cells were then collected and washed 3 times prior to staining as outlined above.
###end p 20
###begin title 21
ANA, dsDNA and ssDNA ELISA
###end title 21
###begin p 22
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr.</sup>
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hCR2</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Blood was collected from age and sex matched 12 B6, 15 B6lpr or 12 B6lpr.hCR2 mice by tail vein nick and allowed to clot. Sera was then applied to a quantitative ANA or qualitative ssDNA and dsDNA ELISA as directed by the manufacturers instructions (Autogen Bioclear,Wiltshire, UK).
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data was analysed and significance between groups was established using PrismGraph 3 software. Student's T test and the Mann-Whitney test were used were appropriate. p < 0.05 was considered significant.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 57 61 57 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
The levels of ANA are significantly reduced in B6lpr.hCR2high mice
###end title 26
###begin p 27
###xml 89 108 89 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib49" ref-type="bibr">Yanaba et al., 2007</xref>
###xml 135 139 135 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 191 252 191 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4 bib23 bib43" ref-type="bibr">Birrell et al., 2005; Kulik et al., 2007; Twohig et al., 2007</xref>
###xml 348 366 348 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Kulik et al., 2007</xref>
###xml 653 656 653 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 748 751 748 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 756 760 756 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 764 767 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 835 838 835 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 843 847 843 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 906 909 906 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 947 953 947 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 968 971 968 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 976 980 976 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1063 1069 1063 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1263 1269 1263 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 422 428 <span type="species:ncbi:9913">bovine</span>
###xml 669 673 <span type="species:ncbi:10090">Mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
###xml 981 985 <span type="species:ncbi:10090">mice</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
###xml 1133 1137 <span type="species:ncbi:10090">mice</span>
###xml 1419 1423 <span type="species:ncbi:10090">mice</span>
The reliance of the CIA model on adjuvant driven antibody production to produce disease (Yanaba et al., 2007) and the inability of hCR2high mice to generate antibody to other model antigens (Birrell et al., 2005; Kulik et al., 2007; Twohig et al., 2007) led us to question whether the marked protection from disease seen in our previous CIA study (Kulik et al., 2007) was due to an inability to generate antibodies to the bovine collagen. To determine whether a similar effect would be seen in the absence of foreign antigen and adjuvant, we opted to test whether expression of the hCR2 tg could prevent onset of spontaneous autoimmune disease on the B6lpr background. Mice were backcrossed for 4 generations and serum collected from at least 12 B6lpr.hCR2high, B6lpr or B6 mice as they reached 6 months of age. The levels of ANA in B6lpr.hCR2high mice were found to be significantly reduced compared to B6lpr mice using a quantitative ANA ELISA (Fig. 1a). However, B6lpr.hCR2high mice still generated significantly higher levels of ANA than age matched B6 mice (Fig. 1a), and there was no visible difference between these groups of mice with respect to the levels of C3 and Ig deposition in the kidney at this time (data not shown). Analysis of ssDNA and dsDNA (Fig. 1b and c) using a semi-quantitative approach confirmed significantly lower levels of ssDNA auto-antigen but only a slight decrease in dsDNA across the mice. This suggested some variation in the extent to which certain auto-antigens were affected as well as underlining that whilst expression of the hCR2 tg is clearly protective in this background, it did not give the relative degree of protection noted in our previous CIA study on the DBA1/j background.
###end p 27
###begin title 28
###xml 17 21 17 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
B cells from hCR2high mice are more susceptible to apoptosis
###end title 28
###begin p 29
###xml 28 32 28 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 174 194 174 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">Birrell et al., 2005</xref>
###xml 233 237 233 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 341 344 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 632 636 632 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 838 844 838 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 929 933 929 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 939 942 939 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 1070 1092 1070 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26" ref-type="bibr">Marchbank et al., 2000</xref>
###xml 1187 1191 1187 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1316 1319 1316 1319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 1326 1332 1326 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1452 1456 1452 1456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1474 1478 1474 1478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1560 1566 1560 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1593 1596 1593 1596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1602 1606 1602 1606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1782 1788 1782 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1843 1846 1843 1846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1852 1856 1852 1856 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1939 1945 1939 1945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 2422 2425 2422 2425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">P1-5</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 982 987 <span type="species:ncbi:10090">mouse</span>
###xml 1192 1196 <span type="species:ncbi:10090">mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">P1-5</span>
###xml 1279 1283 <span type="species:ncbi:10090">mice</span>
###xml 1320 1324 <span type="species:ncbi:10090">mice</span>
###xml 1457 1461 <span type="species:ncbi:10090">mice</span>
###xml 1479 1483 <span type="species:ncbi:10090">mice</span>
###xml 1607 1611 <span type="species:ncbi:10090">mice</span>
###xml 1857 1861 <span type="species:ncbi:10090">mice</span>
Our previous studies in hCR2high mice have revealed a marked change in activation marker profile of B cells in the periphery that is reminiscent of a mild anergic phenotype (Birrell et al., 2005). One marker that was elevated in hCR2high mice was Fas and provides a potential explanation for the difference in protection noted between the B6lpr study and the CIA study, in that the primary mechanism of protection associated with expression of hCR2 could be the removal of B cells by a Fas dependent apoptosis pathway. In order to find evidence for this possibility, we looked at the level of apoptosis in B cells isolated from hCR2high mice as well as additional lines with lower hCR2 expression levels on their B cells. Prior to overnight incubation, the level of hCR2 expression on the splenic B cells was confirmed by flow cytometry (Fig. 2a) and then the levels of apoptosis displayed by the B cell populations from B6, hCR2high, hCR2int and P1-5 mice (genomic hCR2 transgenic mouse expressing hCR2 at the correct developmental point and without the B cell defect (Marchbank et al., 2000)) were established after 16 h. The level of detectable apoptotic B cells in cultures from hCR2high mice was found to be significantly greater than that of both B6 and the P1-5 strain of mice and was notably higher than hCR2int mice (Fig. 2b). This finding led us to examine the baseline levels of apoptosis in freshly isolated BM and splenic B cells from hCR2high mice. Again, hCR2high mice displayed significantly higher levels of apoptosis than the B6 littermates (Fig. 2c and d). Examination of C3-/-. hCR2high mice (i.e. devoid of the main ligands for CR2) suggested that C3 levels were particularly important in determining apoptosis levels during the BM stage of B cell development (Fig. 2c). Analysis of the splenic B cell population in the C3-/-. hCR2high mice also indicated a reduced level of apoptosis but it was not nearly as marked (Fig. 2d). We found that apoptosis levels after 2 h culture were not significantly different from those measured prior to incubation but suggested that there was an increased rate of apoptosis during culture (data not shown). Overall, this data infers that expression level and/or stage of expression of hCR2 is critical in establishing the susceptibility of B cells to apoptosis in culture and might give a reason for the differences between the previous CIA study and the current B6lpr analysis.
###end p 29
###begin title 30
C3 restricts hCR2 expression levels on the B cell surface after sIgM expression
###end title 30
###begin p 31
###xml 103 105 103 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 185 205 185 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">Birrell et al., 2005</xref>
###xml 247 250 247 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 255 259 255 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 524 543 524 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43" ref-type="bibr">Twohig et al., 2007</xref>
###xml 635 638 635 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 642 646 642 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 678 682 678 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 689 695 689 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1114 1120 1114 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1445 1448 1445 1448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
###xml 1365 1369 <span type="species:ncbi:10090">mice</span>
###xml 1679 1684 <span type="species:ncbi:10090">mouse</span>
We have previously shown that hCR2 expression levels drop significantly as the B cells mature from B220lo to B220hi and are reduced further still as B cells migrate into the periphery (Birrell et al., 2005). On analysis of B cells isolated from C3-/- hCR2high mice, we found that this reduction in hCR2 expression levels was no longer apparent, essentially leading to an apparent 3-fold increase in hCR2 expression levels on mature B cells in conjunction with an improvement in the number of B cells reaching the periphery (Twohig et al., 2007). These previous data, together with the data showing that apoptosis levels in the BM of C3-/-hCR2high were reduced compared with hCR2high mice (Fig. 2c), led us to look more closely at the factors involved in the down regulation or selection of cells with low levels of hCR2 in the presence of C3. Examination of BM B cells for intracellular and extracellular expression of sIgM, in conjunction with hCR2 surface expression, demonstrated that sIgM expressing cells had lower levels of hCR2 on the cell surface than B cells which had constructed but not expressed sIgM (Fig. 3). These results were confirmed using several different antibodies to hCR2 in order to control for the potential loss or blocking of antibody binding sites due to the presence and binding of newly formed C3 fragments to CR2 in the C3 sufficient mice (data not shown). When this analysis was subsequently carried out in the C3-/- background, we found that hCR2 expression levels on cells that expressed sIgM were not significantly different from those before sIgM was expressed. Overall, these data suggest that the levels of hCR2 are tightly regulated on the mouse B cell at the point of sIgM expression and that C3 and/or its break down components play an important part in this mechanism.
###end p 31
###begin title 32
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Background strain influences the degree of B cell reduction in hCR2 tg mice
###end title 32
###begin p 33
###xml 97 115 97 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Kulik et al., 2007</xref>
###xml 222 226 222 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 235 238 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 413 417 413 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 518 520 518 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 570 574 570 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 583 586 583 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 653 659 653 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 711 715 711 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 843 849 843 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 938 941 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 1097 1101 1097 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1116 1119 1116 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1236 1239 1236 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1253 1259 1253 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 1318 1322 1318 1322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1347 1350 1347 1350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1472 1478 1472 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 1481 1500 1481 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43" ref-type="bibr">Twohig et al., 2007</xref>
###xml 1676 1682 1676 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 1102 1106 <span type="species:ncbi:10090">mice</span>
###xml 1323 1327 <span type="species:ncbi:10090">mice</span>
###xml 1957 1961 <span type="species:ncbi:10090">mice</span>
During our recent study using CIA, where the hCR2 tg was backcrossed onto the DBA1/j background (Kulik et al., 2007), it quickly became apparent that hCR2 expression levels on mature splenic B cells isolated from both hCR2high and hCR2int mice were at low levels as determined by flow cytometry analysis. Considering the data from above, we studied hCR2 expression levels during B cell development in the DBA.hCR2high mice in comparison to our standard B6 strain. We found that the expression level of hCR2 on the B220lo B cell population of the bone marrow in both hCR2high and hCR2int mice was almost identical between the B6 and DBA strains of mice (Fig. 4a, R1). However, as the B cells matured (become B220high), B cell surface expression of hCR2 was found to be significantly lower in the DBA background than that seen in B6 background (Fig. 4a, R2). This was even more apparent in the mice expressing the intermediate level of hCR2int, where the reduction in hCR2 expression is minimal in the B6 strain but well defined in the DBA background. When this analysis was extended to include hCR2high mice on the B6lpr background, we found that there was no real change in hCR2 expression levels on mature B cells between the B6 and B6lpr backgrounds (Fig. 4b). As previously noted, these data are in contrast to hCR2high mice devoid of C3 (B6.C3-/-) which have a marked increase in hCR2 expression levels on mature B cells compared with their wild type B6 counterparts (Fig. 4b, Twohig et al., 2007). Analysis of surface IgM and hCR2 expression revealed that the reduction in B cell expression of hCR2 in the DBA background appeared to coincide with the expression of sIgM (Fig. 4c). This data demonstrates that strain differences exist in respect to the extent to which hCR2 is considered 'excessive' on the B cell surface during this stage of B cell development. It also indicates that a common mechanism is likely to exist between these two strains of mice and that expression of sIgM triggers cell death and the modulation of hCR2 expression levels seen on mature B cells.
###end p 33
###begin title 34
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
DBA.hCR2high mice have significantly fewer B cells than B6lpr or B6 backgrounds
###end title 34
###begin p 35
###xml 208 212 208 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 253 275 253 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr">Marchbank et al., 2002</xref>
###xml 318 321 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 472 475 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 499 505 499 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 590 594 590 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr.</sup>
###xml 598 602 598 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 695 698 695 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 742 745 742 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 750 754 750 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 766 770 766 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 971 975 971 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 60 75 <span type="species:ncbi:10090">transgenic mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
The first characteristic to be described in the lambda hCR2 transgenic mice is the loss of mature B cells from blood. Analysis of PBL percentages suggested that up to 60% of normal B cells are deleted in hCR2high compared with wild type B6 littermates (Marchbank et al., 2002). Analysis of B cell percentages in B6, B6lpr and DBA strains indicated that these mice display different intrinsic B cell levels in the blood with B6 having the highest percentages followed by B6lpr and DBA, respectively (Fig. 5). Despite our initial thoughts, that there may be a reduction in apoptosis on the B6lpr.hCR2high mice, it was clear that peripheral B cell numbers were reduced in a similar manner in the B6lpr background as seen in the B6 background (B6lpr.hCR2high 52% to hCR2high 53% of normal). However, the expression of hCR2 on B cells in the DBA background results in a further significant reduction in peripheral B cells. In fact, B cells are severely reduced in the DBA.hCR2high mice, with the percentage of B cells in the lymphoid gate dropping to less than 20% of normal (or around 7% of total lymphocytes in the blood compared with nearly 40% in the hCR2 negative DBA littermates).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 117 154 117 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib28" ref-type="bibr">Browning, 2006; Martin and Chan, 2006</xref>
###xml 445 457 445 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">Holers, 2005</xref>
###xml 513 517 513 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 618 636 618 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Kulik et al., 2007</xref>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
Most autoimmune disorders are characterized by the presence of auto-antibodies and abnormalities of B-cell function (Browning, 2006; Martin and Chan, 2006). However, the mechanism(s) that leads to break down of tolerance in B cells remains elusive. There is a growing body of evidence that CR1/CR2 plays an important role in maintaining and defining normal B cell function and thereby helps to prevent the onset of autoimmune disease (reviewed (Holers, 2005)). Our own previous findings demonstrated that the hCR2high mice were almost completely protected from organ specific autoimmune disease (using the CIA model) (Kulik et al., 2007) and raised our hopes that these mice were largely protected from all autoimmune diseases.
###end p 37
###begin p 38
###xml 47 51 47 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr.</sup>
###xml 55 59 55 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 159 165 159 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 316 394 316 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22 bib40 bib41" ref-type="bibr">Izui et al., 1984; Theofilopoulos and Dixon, 1985; Theofilopoulos et al., 1985</xref>
###xml 488 491 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 496 500 496 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 596 602 596 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 682 685 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 693 752 693 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib40 bib41" ref-type="bibr">Theofilopoulos and Dixon, 1985; Theofilopoulos et al., 1985</xref>
###xml 940 943 940 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1266 1269 1266 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1276 1279 1276 1279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1284 1288 1284 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1422 1440 1422 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Kulik et al., 2007</xref>
###xml 1522 1525 1522 1525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1533 1536 1533 1536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1634 1671 1634 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib48" ref-type="bibr">Boackle et al., 2004; Wu et al., 2002</xref>
###xml 2143 2146 2143 2146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 2151 2155 2151 2155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 2331 2368 2331 2368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib48" ref-type="bibr">Boackle et al., 2004; Wu et al., 2002</xref>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 1289 1293 <span type="species:ncbi:10090">mice</span>
###xml 1537 1541 <span type="species:ncbi:10090">mice</span>
###xml 2156 2160 <span type="species:ncbi:10090">mice</span>
These hopes were partially born out, in that B6lpr.hCR2high were found to produce significantly lower levels of ANA than B6lpr mice that did not express hCR2 (Fig. 1a). However, the levels of ANA were not reduced back to the levels found in the B6 strain (which are largely refractory to spontaneous ANA generation (Izui et al., 1984; Theofilopoulos and Dixon, 1985; Theofilopoulos et al., 1985) and the data indicated that significant levels of auto-antibodies still accumulate in the B6lpr.hCR2high mice. This was confirmed, albeit in a qualitative rather than a quantitative anti-ssDNA ELISA (Fig. 1b). Anti-dsDNA are generally accepted as one of the defining features of the MRLlpr model (Theofilopoulos and Dixon, 1985; Theofilopoulos et al., 1985), but this analysis demonstrated that the number of animals with readily detectable anti-dsDNA reactivity was not significantly different between the hCR2 expressing and non-expressing B6lpr littermates. The difference noted between dsDNA and ANA results might be a result of the sensitivity of these different assays or may reflect a selective deletion of particular BCR specificities during B cell development in the presence of hCR2. Analysis of deposited C3 and Ig in several randomly selected kidneys from B6lpr and B6lpr.hCR2high mice (data not shown) also confirmed that the protective effect of hCR2 expression was less obvious than that seen in the CIA model (Kulik et al., 2007). Significant increases in ANA and rheumatoid factor titres have been found in B6lpr and MRLlpr mice in the absence of CR2 but these have little negative effect with respect to renal function (Boackle et al., 2004; Wu et al., 2002) and suggests that whilst CR2 is highly important with respect to the type, level and specificity of auto-antibodies generated in the absence of Fas, it does not dramatically alter the outcome of this autoimmune disease model. Due to a limited amount of sera remaining after the initial analysis, we were unable to establish the effect of hCR2 on other auto-antibodies such as rheumatoid factor but the data herein suggests that certain B cell clones maybe lost in the B6lpr.hCR2high mice that are at least partially beneficial with respect to development and accumulation of ANA. However, as might be predicted from the CR2 knockout studies mentioned above (Boackle et al., 2004; Wu et al., 2002), the presence of hCR2 is not sufficient to completely reverse the autoimmune phenotype in this background.
###end p 38
###begin p 39
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 248 254 248 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 360 363 360 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 475 495 475 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib49" ref-type="bibr">Yanaba et al. (2007)</xref>
###xml 838 842 838 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1026 1029 1026 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1034 1038 1034 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1074 1078 1074 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1091 1097 1091 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 1246 1249 1246 1249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
Analysis of the percentage of B cells in the peripheral blood lymphocyte compartment suggest that there is a significantly higher level of B cell deletion in the DBA background (albeit in a smaller experimental group) than in the B6lpr background (Fig. 5). These data suggest that lack of available B cells in the DBA mice compared to those available in the B6lpr mice could largely explain the difference in hCR2s ability to protect against disease onset. A recent study by Yanaba et al. (2007), where B cells were depleted using anti-CD20 antibodies prior to running the CIA model, clearly demonstrated the importance of B cells in driving disease in the CIA model. Interestingly, the level of B cell deletion (approximately 95%) and the initial outcomes of B cell deletion with anti-CD20 is highly similar to that noted in the DBA.hCR2high mice. These data continue to support the idea that B cells play a significant role in the pathogenesis of CIA and considering B cell numbers are not reduced as significantly in the B6lpr.hCR2high background compared to the DBA.hCR2high background (Fig. 5), offer a very plausible explanation for the difference in the level of protection noted in CIA on the DBA background versus the effects noted in B6lpr model.
###end p 39
###begin p 40
###xml 34 38 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 48 68 48 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">Birrell et al., 2005</xref>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 306 342 306 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib11" ref-type="bibr">Chan et al., 1997; Chan et al., 1999</xref>
###xml 457 475 457 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Kulik et al., 2007</xref>
###xml 570 573 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 595 598 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 849 852 849 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 853 857 <span type="species:ncbi:10090">mice</span>
The failure of "anergic-like" hCR2high B cells (Birrell et al., 2005) to protect from onset of disease in the B6lpr model might fit with the fact that B cells contribute more than just auto-antibodies in the autoimmune response in lupus-prone models, i.e. B cells have an important APC role in these mice (Chan et al., 1997; Chan et al., 1999). As T cell responses were found to be essentially normal in the previous CIA experiment (on the DBA background) (Kulik et al., 2007), it is probably fair to assume that the APC function of B cells or DC remain intact in the B6lpr mice. Thus, in the B6lpr model the ability of T cells to drive B cells to become autoreactive should remain fully intact and suggests that the loss of B cell numbers and the alteration of signalling pathways in the remaining B cell population appears to be overcome in the B6lpr mice through autoreactive T cell help. Together, these data support the notion that the MRL model is primarily reliant on misdirected T cell function/tolerance whilst the CIA model is primarily reliant on misdirected B cell function/tolerance and thus effects from altering signal pathways via BCR and CR2 cross-linking are more likely to have a defined impact in the CIA model.
###end p 40
###begin p 41
###xml 116 134 116 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Kulik et al., 2007</xref>
###xml 230 255 230 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35" ref-type="bibr">Rolink and Melchers, 1996</xref>
###xml 298 302 298 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 407 413 407 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 459 463 459 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 579 585 579 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 681 687 681 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 976 980 976 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1068 1088 1068 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">Goodnow et al., 1988</xref>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
###xml 1037 1044 <span type="species:ncbi:9031">chicken</span>
###xml 1062 1066 <span type="species:ncbi:10090">mice</span>
We have previously postulated that expression of hCR2 in the bone marrow influences the signal through the Pre-BCR (Kulik et al., 2007), which is normally required to allow B cells to progress along the B cell maturation pathway (Rolink and Melchers, 1996). Analysis of apoptosis levels in the hCR2high mice established that they had an increased basal rate of apoptosis in both the bone marrow and spleen (Fig. 2). This data suggests that B cells in the hCR2high mice are highly susceptible to apoptosis, particularly at the point of surface IgM expression. The presence of C3 (Fig. 3) appears to be linked directly to the reduction of CR2 expression level on the B cell surface (Fig. 4a) and suggests that hCR2, interacting with C3 and the sIgM/BCR is interfering with the normal negative selection process. This could be a result of hCR2 modulating the level of signal perceived from the sIgM. In order to investigate this assertion, we are currently crossbreeding the hCR2high line with mice expressing only BCR with specificity for chicken lysozyme (HEL tg mice (Goodnow et al., 1988)).
###end p 41
###begin p 42
###xml 152 169 152 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib44" ref-type="bibr">Wang et al., 2003</xref>
###xml 275 278 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 460 466 460 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 658 661 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 821 841 821 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib50" ref-type="bibr">Yoshida et al., 2000</xref>
###xml 892 895 892 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 964 970 964 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 1142 1146 1142 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1153 1156 1153 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1161 1165 1161 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
###xml 1166 1170 <span type="species:ncbi:10090">mice</span>
The fact that genetic background and the selection of the naive B cell repertoire have been linked to the susceptibility of mice to autoimmune disease (Wang et al., 2003) supports the idea that hCR2 can amplify normal selective pressure in this model. Certainly B6 and the B6lpr strain have a marked decrease in B cells transiting the BM compared with hCR2 negative littermates but surprisingly the DBA mice have the fewest surviving B cells in the periphery (Fig. 5) and suggests that they have a highly restricted B cell repertoire which is being further tightened in the presence of hCR2. Direct analysis of B cell susceptibility to altered deletion in B6lpr might be informative. However, it has already been established that deletion of autoreactive B cells after BCR ligation occurs unabated in the absence of Fas (Yoshida et al., 2000) and we found that the levels of B cells in the B6lpr.hCR2 mice were essentially identical to those seen in B6.hCR2 mice (Fig. 5). Thus, as the effects of hCR2 expression appear to be exerted on the BCR signalling pathways it seems unlikely that significant differences would be seen between the hCR2high and B6lpr.hCR2high mice.
###end p 42
###begin p 43
###xml 118 122 118 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 266 284 266 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Kulik et al., 2007</xref>
###xml 320 322 320 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 521 542 521 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">Benschop et al., 2001</xref>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
Corroborating evidence for enhanced BCR signalling being the likely mechanism behind the altered phenotype in the hCR2high mice can be found in the altered patterns of tyrosine phosphorylated proteins in B cells from hCR2 tg mice before and after BCR cross-linking (Kulik et al., 2007). Interestingly, mobilization of Ca2+ in immature B cells has been found to be much greater than that seen in mature B cells, presumably to amplify weak signals in the BM environment and delete autoreactive B cells from the repertoire (Benschop et al., 2001). It thus seems plausible that additional signal amplification via hCR2 in the BM is likely to disrupt these highly sensitive signalling networks resulting in the higher levels of apoptosis found and the increase in anergy in the remaining B cells.
###end p 43
###begin p 44
###xml 613 617 613 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
The data presented here continues to suggest that CR2 expression levels are a critical factor in determining B cell function. The signal generated through hCR2 is apparently a modifier of the BCR signal since numbers of pro-B cells and hCR2 expression levels are 'normal' until surface BCR is expressed in the BM. It is possible that additional signalling molecules expressed at the same point as sIgM may interact with hCR2 and thus sIgM might only be a marker of the time when such changes take place. Nevertheless, it is clear that examination of the proteins and signalling molecules being altered in the hCR2high mice at the point that of BCR, hCR2 and (self) antigen contact will provide a fuller understanding of the molecules involved in B cell survival and selection of the BCR repertoire. This should also provide a greater understanding of the mechanisms that predispose B cells to break tolerance in certain genetic backgrounds.
###end p 44
###begin title 45
Acknowledgements
###end title 45
###begin p 46
The authors would like to thank the Northern Counties Kidney research Fund (KJM) and the Wellcome Trust (IYP, KJM: WT068541) and the NIH (VHM, NIHR01 AI31105) for supporting this work. We would also like to thank the members of the animal facilities at Newcastle University and the UCDSOM.
###end p 46
###begin title 47
References
###end title 47
###begin article-title 48
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21)
###end article-title 48
###begin article-title 49
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
###end article-title 49
###begin article-title 50
Unique signalling properties of B cell antigen receptor in mature and immature B cells: implications for tolerance and activation
###end article-title 50
###begin article-title 51
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 41 46 <span type="species:ncbi:9606">human</span>
B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens
###end article-title 51
###begin article-title 52
CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE
###end article-title 52
###begin article-title 53
###xml 29 35 <span type="species:ncbi:10090">murine</span>
Cr2, a candidate gene in the murine sle1c lupus susceptibility locus, encodes a dysfunctional protein
###end article-title 53
###begin article-title 54
###xml 44 49 <span type="species:ncbi:9606">human</span>
The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules
###end article-title 54
###begin article-title 55
B cells move to centre stage: novel opportunities for autoimmune disease treatment
###end article-title 55
###begin article-title 56
The role of complement in B cell activation and tolerance
###end article-title 56
###begin article-title 57
###xml 32 38 <span type="species:ncbi:10090">murine</span>
The roles of B cells in MRL/lpr murine lupus
###end article-title 57
###begin article-title 58
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus
###end article-title 58
###begin article-title 59
Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease
###end article-title 59
###begin article-title 60
The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity
###end article-title 60
###begin article-title 61
###xml 39 45 <span type="species:ncbi:10090">murine</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21)
###end article-title 61
###begin article-title 62
Regulation of the B cell response to T-dependent antigens by classical pathway complement
###end article-title 62
###begin article-title 63
###xml 93 108 <span type="species:ncbi:10090">transgenic mice</span>
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice
###end article-title 63
###begin article-title 64
###xml 14 20 <span type="species:ncbi:10090">murine</span>
Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction
###end article-title 64
###begin article-title 65
###xml 72 96 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses
###end article-title 65
###begin article-title 66
Suppression of the immune response by a soluble complement receptor of B lymphocytes
###end article-title 66
###begin article-title 67
In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody
###end article-title 67
###begin article-title 68
Complement receptors and the shaping of the natural antibody repertoire
###end article-title 68
###begin article-title 69
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Induction of various autoantibodies by mutant gene lpr in several strains of mice
###end article-title 69
###begin article-title 70
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development
###end article-title 70
###begin article-title 71
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1
###end article-title 71
###begin article-title 72
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia
###end article-title 72
###begin article-title 73
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function
###end article-title 73
###begin article-title 74
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)
###end article-title 74
###begin article-title 75
B cell immunobiology in disease: evolving concepts from the clinic
###end article-title 75
###begin article-title 76
Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19
###end article-title 76
###begin article-title 77
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
###end article-title 77
###begin article-title 78
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2
###end article-title 78
###begin article-title 79
###xml 43 61 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes
###end article-title 79
###begin article-title 80
A critical role for complement in maintenance of self-tolerance
###end article-title 80
###begin article-title 81
Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex
###end article-title 81
###begin article-title 82
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
B-cell development in the mouse
###end article-title 82
###begin article-title 83
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice
###end article-title 84
###begin article-title 85
###xml 35 40 <span type="species:ncbi:9606">human</span>
Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody
###end article-title 85
###begin article-title 86
The CD19/CD21 signal transduction complex of B lymphocytes
###end article-title 86
###begin article-title 87
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine models of systemic lupus erythematosus
###end article-title 87
###begin article-title 88
Autoimmune aspects of systemic lupus erythematosus
###end article-title 88
###begin article-title 89
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo
###end article-title 89
###begin article-title 90
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 89 104 <span type="species:ncbi:10090">transgenic mice</span>
Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3
###end article-title 90
###begin article-title 91
The naive B cell repertoire predisposes to antigen-induced systemic lupus erythematosus
###end article-title 91
###begin article-title 92
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 61 79 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins
###end article-title 92
###begin article-title 93
###xml 124 132 <span type="species:ncbi:9606">patients</span>
Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus
###end article-title 93
###begin article-title 94
Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus
###end article-title 94
###begin article-title 95
A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus
###end article-title 95
###begin article-title 96
###xml 54 58 <span type="species:ncbi:10090">mice</span>
B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity
###end article-title 96
###begin article-title 97
###xml 202 206 <span type="species:ncbi:10090">mice</span>
Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice
###end article-title 97
###begin p 98
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 166 170 166 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 174 182 174 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr.hCR2</sup>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 421 422 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 447 448 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
Significantly less ANA are detectable in B6lpr mice which express hCR2. Serum was collected from 12 C57Bl/6j (B6), 15 C57Bl/6j-Faslpr/Faslpr (B6lpr) and 12 B6lpr.hCR2high (B6lpr.hCR2) mice at 6 month of age and applied to commercially available quantitative ANA ELISA (a) or qualitative anti-ssDNA ELISA (b) or anti-dsDNA ELISA (c) following manufacturers instructions. Significance was calculated by Students T test. ***p < 0.0001, **p < 0.001, *p < 0.05.
###end p 98
###begin p 99
###xml 458 461 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 472 476 472 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 778 782 778 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 801 804 801 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 807 810 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 823 826 823 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 831 835 831 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 839 842 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 904 905 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 916 917 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">P1-5</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
Apoptosis is increased in HCR2 tg mice. Splenocytes were isolated from littermates of each genotype as indicated in the methods section. (a) Cells were stained with B220 and b171 to confirm the expression level of hCR2 on B cells isolated from the mice indicated. (b) Cells were incubated overnight in standard tissue culture conditions and then stained with anti-B220 and FITC-VAD-FMK to identify apoptotic B cells. 3 C57Bl/6j (B6), 5 P1-5 (hCR2 tg), 3 hCR2int and 3 hCR2high mice were examined (each data point is the mean apoptosis value from 3 separate culture wells). (c) Freshly isolated bone marrow and (d) Splenocytes were stained with anti-B220-APC (to identify B cells) and FITC-VAD-FMK (to identify apoptotic cells). Groups of 6 mice were analysed; C57Bl/6 (B6), hCR2high (hCR2); C57Bl/6.C3-/-(C3-/-), C57Bl/6.C3-/-.hCR2high (C3-/-hCR2). Mann-Whitney test was used to establish significance. *p < 0.05, **p < 0.01.
###end p 99
###begin p 100
###xml 17 21 17 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 128 132 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 139 142 139 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 146 150 146 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
B cells from hCR2high mice express less hCR2 after sIgM expression in the presence of C3. BM cells were collected from C3+/+hCR2high and C3-/-hCR2high mice as described in materials and methods. BM lymphocytes were stained for B220+ and hCR2 followed by staining for IgM before (Extracellular) or after (Intracellular) incubation with fix/perm (BD biosciences, Oxford, UK). Dot plots show B220-FITC+ cells expressed as hCR2-PE (Bly-4) versus anti-IgM-Cy5.5. Results shown are representative of 3 independent experiments involving 10 mice from each genotype in total.
###end p 100
###begin p 101
###xml 127 131 127 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 140 143 140 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 323 326 323 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 350 354 350 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 432 436 432 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 440 444 440 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hCR2</sup>
###xml 451 454 451 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 459 463 459 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 467 475 467 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr.hCR2</sup>
###xml 490 493 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 498 502 498 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 506 513 506 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;hCR2</sup>
###xml 532 536 532 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 541 545 541 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hCR2</sup>
###xml 818 822 818 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 882 883 882 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
hCR2 expression level is dependent on mouse strain. (a) Representative plots of BM cells isolated from age and sex matched hCR2high and hCR2int mice on the DBA/1j and C57Bl/6 background are shown. B220-FITC was used to identify B cells and hCR2 expression was assessed using biotin-171 + SA-PE. R1 and R2 delineate the B220low (pre/immature) and B220high (mature) B cell population, respectively. (b) Splenocytes from 8 C57Bl/6.hCR2high (B6hCR2), 9 B6lpr.hCR2high (B6lpr.hCR2), 7 C57Bl/6.C3-/-.hCR2high (C3-/-hCR2) and 5 DBA/1j.hCR2high (DBAhCR2) were stained with B220 and b171 to establish the relative level of hCR2 expression on mature B cells in these strains. The mean value of each group is shown next to each group and illustrated by the horizontal bar. (c) BM cells were isolated from age and sex matched hCR2high mice on the B6 and DBA background. Dot plots show B220-FITC+ cells expressed as hCR2 (biotin 171 + SA-PE) versus anti-IgM-Cy5.5 (extracellular). 10,000 B cells were collected by FACS and results are representative of at least 5 mice analysed for each strain.
###end p 101
###begin p 102
###xml 495 499 494 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 503 507 502 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hCR2</sup>
###xml 522 525 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 529 532 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 547 550 546 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 555 559 554 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 563 570 562 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;hCR2</sup>
###xml 589 592 588 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 596 599 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 603 606 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 614 617 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 622 626 621 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 630 633 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 633 637 632 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hCR2</sup>
###xml 673 677 672 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 682 686 681 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hCR2</sup>
###xml 1095 1099 1094 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 924 928 <span type="species:ncbi:10090">mice</span>
Peripheral B cell percentages are dependent on background strain. Blood from mice was collected into 20 mul of heparin and red cells lysed. B cells and T cells were further identified by B220 and CD3, respectively. Fixed samples were then assessed by flow cytometry. PBL were identified by their forward and side scatter profile and the relative percentage of B220 positive cells falling in the lymphoid gate was calculated for each strain of mouse as indicated. 15 C57Bl/6 (B6), 15 C57Bl/6.hCR2high (B6hCR2), 6 C57Bl/6.C3-/- (C3-/-), 7 C57Bl/6.C3-/-.hCR2high (C3-/-hCR2), 15 C57Bl/6j- Faslpr/Faslpr (B6lpr), 12 B6lpr.hCR2high (B6lprhCR2), 8 DBA/1j (DBA) and 5 DBA/1j .hCR2high (DBAhCR2) were analysed. Wild type mice (hCR2 negative) are represented by the filled-in symbols for each strain and the open symbols represent mice that express hCR2. The mean value for the percentage B cells found in the blood of each group of mice is illustrated by the horizontal line. The reduction in B cell percentages (from that normally seen in the hCR2 negative littermates) is shown directly above the hCR2high expressing groups.
###end p 102

